Mallinckrodt Mulls Restructuring as a Major Opioid Trial Nears

Sept. 4, 2019, 8:55 PM UTCUpdated: Sept. 5, 2019, 4:49 PM UTC

Facing more than 2,000 states, cities and counties that blame drug makers and distributors for an epidemic of addiction and tens of thousands of overdose deaths, Mallinckrodt Plc has hired restructuring advisers to help limit its potential legal liabilities.

Drugmakers such as Mallinckrodt, Purdue Pharma LP and others are facing claims that they downplayed the addictive risks of their opioid pills and failed to monitor patterns of misuse. With their potential liability running into the tens of billions of dollars, some have raised the possibility of bankruptcy as a way to contain a likely legal payout.

Ahead of the first ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.